Centene forward PE CNC
Share price divided by analysts' consensus earnings for the next twelve months, since 2001.
- Today, Oct 23, 2026
- 15.0×
- 10-year median
- 14.4×
- Against its 10-year history
- 56th
- percentile: 0 is its lowest day, 100 its highest
- 10-year range
- 8.6× to 64.5×
- Peer median
- 13.8×
Centene's forward PE is 15.0× as of Oct 23, 2026.
That is above its ten-year median of 14.4×, close to the middle of its last ten years.
Over that time it ranged from 8.6× in Sep 2019 to 64.5× in May 2025.
The median for 5 health insurers of a similar size is 13.8×.
Forward PE over time
The dashed line is the 10-year median and the shaded band the middle half of its days.
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 15.0× | 13.3× | 21.3× |
| 2025 | 18.5× | 13.1× | 64.5× |
| 2024 | 20.3× | 10.2× | 21.5× |
| 2023 | 12.5× | 10.0× | 12.6× |
| 2022 | 12.8× | 12.1× | 16.6× |
| 2021 | 15.0× | 10.9× | 15.4× |
| 2020 | 13.6× | 10.2× | 16.3× |
| 2019 | 12.6× | 8.6× | 15.8× |
| 2018 | 13.5× | 13.5× | 18.6× |
| 2017 | 16.9× | 13.8× | 18.3× |
| 2016 | 12.8× | 11.4× | 18.5× |
| 2015 | 18.4× | 15.9× | 28.3× |
| 2014 | 19.9× | 14.3× | 20.1× |
| 2013 | 18.6× | 16.5× | 24.3× |
| 2012 | 18.2× | 17.7× | 37.4× |
| 2011 | 26.8× | 14.2× | 27.0× |
| 2010 | 14.1× | 11.0× | 15.9× |
| 2009 | 12.6× | 8.6× | 13.0× |
| 2008 | 11.0× | 7.5× | 14.5× |
| 2007 | 14.1× | 10.2× | 20.9× |
Against its peers
Companies in Medical - Healthcare Plans nearest Centene's size, closest first, today.
| Company | Forward PE |
|---|---|
| CNCCentene | 15.0× |
| HUMHumana | 33.7× |
| CICigna | 9.7× |
| ELVElevance Health | 16.1× |
| CVSCVS Health | 11.5× |
| OSCROscar Health | n/m |
| Peer median | 13.8× |
Where Centene ranks
What the forward PE tells you
Price divided by what analysts expect the company to earn over the next twelve months. It answers "what am I paying for next year" instead of last year.
Estimates are opinions. When forward PE is far below trailing PE, analysts expect a big jump in earnings. If that jump slips, the stock was not as cheap as it looked.
More on Centene
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.